Alx Oncology Holdings ALXO Insider Ownership

NASDAQ ALXO
$1.24 0.00 (-0.40%)
As of: Oct 21, 2026 · 10:11 AM EDT

Insider Holdings by Owner

9.97Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
10.22%
▼-0.322% pp QoQ
Shares Held by Insiders
14.12Mn
filed for Sep 2026
▼-3.06% QoQ
Shares Outstanding
138.22Mn
138,216,247 shares
Direct Holdings
1.07Mn
Indirect: 13.05Mn
Net Shares Traded (QoQ)
-445.43K
net selling in Sep 2026
Insiders Holding Shares
8
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Across the past 12 months, open-market trades by Alx Oncology Holdings insiders totaled $5 million in purchases (3.18Mn shares) and $42,588 in sales (21.91K shares).

Form 4 Holdings

Insiders Holding ALXO

Insiders 8
Shares held 9.97Mn
Of outstanding 7.21%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Corey S Goodman Director, TenPercentOwner 0 8,453,038 8,453,038 84.8% 04 Feb, 2026
2 Jaume Pons President Cso 579,388 0 579,388 5.8% 21 Feb, 2025
3 Sophia Randolph Chief Medical Officer 325,711 0 325,711 3.3% 16 Aug, 2024
4 Jason Lettmann Chief Executive Officer 294,379 0 294,379 3.0% 18 Aug, 2026
5 Peter S Garcia Chief Financial Officer 121,516 0 121,516 1.2% 16 Aug, 2024
6 Shelly Wong Svp, Finance And Cao 87,828 0 87,828 0.9% 18 Aug, 2026
7 Harish Shantharam Chief Financial Officer 75,000 0 75,000 0.8% 20 Aug, 2025
8 Rekha Hemrajani Director 33,000 0 33,000 0.3% 04 Dec, 2024

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

432 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
17 Aug, 2026 Shelly Wong Svp, Finance And Cao Disposed S 573 $1.93 $1.11K 87,828 Direct
17 Aug, 2026 Jason Lettmann Chief Executive Officer Disposed S 2,230 $1.93 $4.30K 294,379 Direct
01 Jul, 2026 Shelly Wong Svp, Finance And Cao Disposed S 1,404 $2.04 $2.86K 88,401 Direct
16 Apr, 2026 Barbara Klencke Chief Medical Officer Acquired A 100,000 $0.00 $0 100,000 Direct
16 Apr, 2026 Jeff E. Knight Chief Dev Operating Officer Acquired A 800,000 $0.00 $0 800,000 Direct
19 Mar, 2026 Shelly Pinto Svp, Finance And Cao Disposed S 903 $2.17 $1.96K 86,805 Direct
19 Mar, 2026 Jason Lettmann Chief Executive Officer Disposed S 12,311 $2.17 $26.71K 293,609 Direct
03 Mar, 2026 Barbara Klencke Chief Medical Officer Acquired A 700,000 $0.00 $0 700,000 Direct
18 Feb, 2026 Shelly Pinto Svp, Finance And Cao Disposed S 565 $2.27 $1.28K 87,708 Direct
17 Feb, 2026 Jason Lettmann Chief Executive Officer Disposed F 2,201 $2.27 $5.00K 305,920 Direct
02 Feb, 2026 Corey S Goodman Director, TenPercentOwner Acquired P 3,184,713 $1.57 $5.00Mn 8,453,038 Indirect
26 Jan, 2026 Shelly Pinto Svp, Finance And Cao Acquired A 192,000 $0.00 $0 192,000 Direct
26 Jan, 2026 Jason Lettmann Chief Executive Officer Acquired A 912,000 $0.00 $0 912,000 Direct
26 Jan, 2026 Harish Shantharam Chief Financial Officer Acquired A 303,000 $0.00 $0 303,000 Direct
20 Jan, 2026 Chris H Takimoto Director Acquired A 40,400 $0.00 $0 40,400 Direct
20 Jan, 2026 Daniel J. Curran Director Acquired A 16,833 $0.00 $0 16,833 Direct
20 Jan, 2026 J. Scott Garland Director Acquired A 40,400 $0.00 $0 40,400 Direct
20 Jan, 2026 Rekha Hemrajani Director Acquired A 40,400 $0.00 $0 40,400 Direct
20 Jan, 2026 Corey S Goodman Director, TenPercentOwner Acquired A 40,400 $0.00 $0 40,400 Direct
20 Jan, 2026 Alan B. Sandler Director Acquired A 10,100 $0.00 $0 10,100 Direct